Publication | Closed Access
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma
322
Citations
35
References
2021
Year
Biomarker AnalysesMedicineMelanomaImmunologyImmune Checkpoint InhibitorStage Iii MelanomaCancer TreatmentImmunotherapyOncologyRadiation OncologySkin Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1